Emma Walmsley

HP Inc. has appointed Emma Walmsley, the former chief executive of pharmaceutical giant GSK, as its new CEO. The move marks a striking cross-industry shift, with Walmsley moving from healthcare to technology. Commentators are weighing what her leadership background means for HP's future strategy and direction.

HP has appointed Emma Walmsley, until now best known as chief executive of pharmaceutical giant GSK, as its new chief executive. The surprise move puts one of Britain's most prominent business leaders at the helm of a major American technology company, and investors and analysts are weighing what her consumer-health background means for HP's future strategy.

Emma Walmsley, who led pharmaceutical giant GSK for nearly a decade, has been named the new chief executive of HP. The appointment marks an unusual jump from pharma to the technology hardware sector, and commentators are weighing what her leadership experience could mean for HP's strategic direction. The move is drawing broad attention across business and tech circles internationally.

HP Inc. has appointed Emma Walmsley as its chief executive officer, effective January 4, 2027. Interim CEO Bruce Broussard will step down when the transition takes effect. Walmsley, previously best known for leading GlaxoSmithKline, moves into one of the most prominent roles in US technology hardware, and the surprise cross-industry choice is drawing attention from investors and business commentators.

HP Inc. has appointed Emma Walmsley as its new chief executive. Walmsley, previously chief executive of pharmaceutical company GSK and a Microsoft board member, takes on the role as HP navigates a memory-chip shortage and a broader industry downturn. The move links the PC maker's leadership to one of the most prominent women in global business, and observers are watching how she steers the company through tough hardware market conditions.